Fmr LLC Neogenomics Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Fmr LLC holds 12,324 shares of NEO stock, worth $203,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,324

Previous 15,216 19.01%

Holding current value

$203,099

Previous $239,000 28.87%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$13.01 - $15.77 $37,624 - $45,606	-2,892 Reduced 19.01%	12,324 $170,000
Q1 2024 May 13, 2024	BUY	$14.06 - $16.79 $9,321 - $11,131	663 Added 4.56%	15,216 $239,000
Q4 2023 Feb 13, 2024	BUY	$11.67 - $20.73 $75,166 - $133,521	6,441 Added 79.4%	14,553 $235,000
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $5,576 - $8,193	-459 Reduced 5.36%	8,112 $99,000
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $10,264 - $14,436	-728 Reduced 7.83%	8,571 $137,000
Q1 2023 May 11, 2023	BUY	$9.09 - $19.45 $12,753 - $27,288	1,403 Added 17.77%	9,299 $161,000
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $40,925 - $76,584	-6,345 Reduced 44.55%	7,896 $72,000
Q3 2022 Nov 10, 2022	BUY	$7.86 - $12.91 $27,667 - $45,443	3,520 Added 32.83%	14,241 $122,000
Q2 2022 Aug 12, 2022	BUY	$7.06 - $13.97 $59,988 - $118,703	8,497 Added 382.06%	10,721 $88,000
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $4,094 - $11,889	337 Added 17.86%	2,224 $27,000
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $5,427 - $8,631	-178 Reduced 8.62%	1,887 $65,000
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $40,535 - $51,101	973 Added 89.1%	2,065 $99,000
Q2 2021 Aug 13, 2021	BUY	$36.62 - $51.69 $39,989 - $56,445	1,092 New	1,092 $49,000

Others Institutions Holding NEO

# of Institutions

278

Shares Held

127M

Call Options Held

581K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.07B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account